VITROS IMMUNODIAGNOSTICS PRODUCTS TROPI ES REAGENT PACK
Report
- Report Number
- 3007111389-2015-00107
- Event Type
- Malfunction
- Date Received
- May 4, 2015
- Date of Event
- March 29, 2015
- Report Date
- May 4, 2015
- Manufacturer
- ORTHO-CLINICAL DIAGNOSTICS
- Product Code
- MMI
- Product Problem
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- TX, US
- Reporter Occupation
- MEDICAL TECHNOLOGIST
Narratives
THE INVESTIGATION DETERMINED THAT NON-REPRODUCIBLE, HIGHER THAN EXPECTED VITROS TROPONIN I ES RESULTS WERE OBTAINED FOR TWO PATIENT SAMPLES USING VITROS TROPI ES REAGENT ON A VITROS ECIQ IMMUNODIAGNOSTIC SYSTEM. ROOT CAUSE FOR THE EVENTS COULD NOT BE DETERMINED; HOWEVER, PRE-ANALYTICAL SAMPLE HANDLING OR A POSSIBLE VITROS TROPI ES REAGENT ISSUE COULD NOT BE RULED OUT AS CONTRIBUTING FACTORS TO THE EVENTS. THE INVESTIGATION WAS ABLE TO RULE OUT A 5600 SYSTEM MALFUNCTION AS A CONTRIBUTING FACTOR.
THE CUSTOMER OBTAINED NON-REPRODUCIBLE, HIGHER THAN EXPECTED VITROS TROPONIN I ES RESULTS FOR TWO PATIENT SAMPLES USING VITROS TROPI ES REAGENT ON A VITROS ECIQ IMMUNODIAGNOSTIC SYSTEM. PATIENT 1 VITROS TROPI ES RESULT: 0.157 NG/ML V S 0.018 NG/ML. PATIENT 2 VITROS TROPI ES RESULT: 0.121 NG/ML V S <0.012 NG/ML. BIASED RESULTS OF THE DIRECTION AND MAGNITUDE OBSERVED COULD LEAD TO INAPPROPRIATE PHYSICIAN ACTION. THE RESULT FROM PATIENT 1 WAS REPORTED OUTSIDE OF THE LABORATORY AND A CORRECTED REPORT WAS ISSUED. THE RESULT FROM PATIENT 2 WAS NOT REPORTED FROM THE LABORATORY. THERE WERE NO ALLEGATIONS OF PATIENT HARM MADE AS A RESULT OF THE EVENTS. THIS REPORT IS NUMBER TWO OF TWO MDR¿S FOR THIS EVENT. TWO 3500A FORMS ARE BEING SUBMITTED FOR THIS EVENT AS TWO DEVICES WERE INVOLVED. THIS REPORT CORRESPONDS TO ORTHO CLINICAL DIAGNOSTICS INC. (B)(4).
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 291029 | VITROS IMMUNODIAGNOSTICS PRODUCTS TROPI ES REAGENT PACK | IN-VITRO DIAGNOSTIC | MMI | ORTHO-CLINICAL DIAGNOSTICS | 1755 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 |